44 – How to Turn "The Good, the Bad, and the Ugly" of Pharma Data into a Trusted Asset

Your host Alex Shevelenko welcomes Michelle Bridenbaker, Global Head of Medical Excellence and Communications at Recordati, Vice President of MILE, and CEO of Unbiased Science. In this episode, Michelle shares her visionary take on why scientific transparency and human empathy are critical to cutting through the modern "attention economy," especially in a world where social media algorithms and generative AI are rapidly rewriting the rules of healthcare communication.Michelle discusses the evolution of her thinking from serving on the frontlines as a critical care nurse to stepping into global leadership roles across drug safety and medical affairs. She explains why modern medical communication often feels like a misunderstood struggle, with clinicians hollowing out their limited patient time to meet heavy administrative demands. She introduces the concept of navigating "the good, the bad, and the ugly" of data—a blueprint for balancing highly regulated information with the narrow, disciplined focus required to solve a patient's or clinician's most urgent health literacy needs. As the conversation explores the future of AI, Michelle highlights why the speed of generative tools cannot replace the "human connection" of a trusted messenger, and why the most resilient healthcare organizations will be those that prioritize verified, guardrailed data environments over generic internet content.The conversation also touches on the practicalities of leadership and the psychology of public trust, including Michelle’s advice on how to move beyond defensive, judgmental communication by adopting an empathetic, open-ended approach to patient inquiries. She shares insights from her decades spent analyzing how information spreads across global, multicultural markets, explaining how practicing radical transparency and data literacy can protect a company’s compliance and even save a clinician's professional trust. This episode serves as a masterclass for any life sciences leader looking to move beyond "innovation theater" and build an communication ecosystem that is philosophically and technically equipped to stay trusted in an era of unprecedented digital uncertainty.To connect with Michelle, find her on LinkedIn or follow her insights at unbiasedscipod.com. You can also visit mile-association.org to see her vision for high-integrity medical information leadership in action. Don't just build a product—build the trust to solve the world's problems!Want to be a guest on the show? Contact us HERE. To learn more about RELAYTO, visit: relayto.com.